News

The CHMP recommendation will now be forwarded to the European Commission for final marketing approval, which typically occurs within 60 to 90 days. Once the product receives its

The company is seeking approval to use the assay to screen for HBV on both its semi-automated instrument platform and on the fully automated, high-throughput Tigris system. Hank

Spacelabs patient monitors provide clinicians with a large display unit and comprehensive monitoring capabilities at the bedside while also enabling clinicians to monitor patients wirelessly as they are

The decision prevents Ranbaxy from launching its drug before Lipitor’s basic patent expires in November 2011. Ranbaxy can seek to appeal the decision to the Supreme Court of

An initial Phase I pharmacokinetics, biodistribution and dosimetry study (BC1-08) with Alpharadin in HRPC patients with skeletal metastases will be conducted at the Memorial Sloan-Kettering Cancer Center in

The trial was initiated after the approval from the Medicines and Healthcare Products Regulatory Agency [MHRA] in the UK. The company intends to develop GRC 4039, a PDE

Under an exclusive marketing agreement, Neurobiological receives quarterly royalty payments on sales of Memantine by Merz and its marketing partners. Paul Freiman, president and CEO of Neurobiological, said:

Under the terms of the agreement VersaWave and DioDent Micro 980 lasers will be utilized at LVI’s state-of-the-art teaching facility through 2009. The educational alliance is the latest

Under the terms of the agreement, Celgene and Acceleron will jointly develop, manufacture and commercialize Acceleron’s products for bone loss. Celgene will make an upfront payment to Acceleron